Ignite Creation Date:
2024-05-06 @ 1:41 PM
Last Modification Date:
2024-10-26 @ 1:18 PM
Study NCT ID:
NCT04097561
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2019-09-19
Brief Title:
Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies Phoebe
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institutes of Health Clinical Center CC